MIRA Pharmaceuticals (MIRA)

• Market cap: $30M
• 1 day: -5.88%
• 5 days: -11.66%
• 1 month: 6.67%
• 3 months: 0.7%
• 6 months: 20%
• Year to date: 25.22%
• 1 year: -15.29%
• 5 years: -80.59%
• 10 years: -80.59%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5